125 related articles for article (PubMed ID: 38102054)
1. Serum elastase-1 predicts malignancy in intraductal papillary mucinous neoplasm of the pancreas.
Mishima T; Takano S; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Hosokawa I; Konishi T; Nishino H; Nakada S; Kouchi Y; Kishimoto T; Ohtsuka M
Pancreatology; 2024 Feb; 24(1):93-99. PubMed ID: 38102054
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.
Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH
Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906
[TBL] [Abstract][Full Text] [Related]
3. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study.
Kim TH; Song TJ; Hwang JH; Yoo KS; Lee WJ; Lee KH; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Kim EY; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Oh DW; Kim MH
Pancreatology; 2015; 15(4):405-10. PubMed ID: 25998516
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
[TBL] [Abstract][Full Text] [Related]
5. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules.
Ohno E; Hirooka Y; Itoh A; Ishigami M; Katano Y; Ohmiya N; Niwa Y; Goto H
Ann Surg; 2009 Apr; 249(4):628-34. PubMed ID: 19300203
[TBL] [Abstract][Full Text] [Related]
6. Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI.
Min JH; Kim YK; Kim SK; Kim H; Ahn S
Eur Radiol; 2021 Jul; 31(7):4774-4784. PubMed ID: 33409798
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas.
Qian Y; Gong Y; Luo G; Liu Y; Wang R; Zou X; Deng S; Lin X; Chen Y; Wang X; Yu X; Cheng H; Liu C
World J Surg Oncol; 2022 Sep; 20(1):310. PubMed ID: 36155113
[TBL] [Abstract][Full Text] [Related]
8. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas using MR findings and texture analysis.
Jeon SK; Kim JH; Yoo J; Kim JE; Park SJ; Han JK
Eur Radiol; 2021 May; 31(5):3394-3404. PubMed ID: 33140171
[TBL] [Abstract][Full Text] [Related]
9. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
[TBL] [Abstract][Full Text] [Related]
10. The association between serum ferritin levels and malignant intraductal papillary mucinous neoplasms.
Zhuge X; Zhou H; Chen L; Chen H; Chen X; Guo C
BMC Cancer; 2021 Nov; 21(1):1253. PubMed ID: 34800987
[TBL] [Abstract][Full Text] [Related]
11. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
12. Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail.
Zhou H; Li X; Wang Y; Wang Z; Zhu J; Wang Z; Chen X
BMC Gastroenterol; 2022 Nov; 22(1):473. PubMed ID: 36402960
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Malignancy Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT.
Chai L; Zhu N; Wang Q; Wang T; Chai W
Acad Radiol; 2021 May; 28(5):679-686. PubMed ID: 32591278
[TBL] [Abstract][Full Text] [Related]
14. Predictors of malignancy in main duct intraductal papillary mucinous neoplasm of the pancreas.
Uehara H; Abe Y; Kai Y; Takada R; Yamai T; Nakabori T; Ikezawa K; Takahashi H; Ohkawa K
Gastrointest Endosc; 2022 Feb; 95(2):291-296. PubMed ID: 34474037
[TBL] [Abstract][Full Text] [Related]
15. Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
Pedrazzoli S; Sperti C; Pasquali C; Bissoli S; Chierichetti F
Ann Surg; 2011 Dec; 254(6):971-6. PubMed ID: 22076067
[TBL] [Abstract][Full Text] [Related]
16. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
17. Threshold of Main Pancreatic Duct Diameter in Identifying Malignant Intraductal Papillary Mucinous Neoplasm by Magnetic Resonance Imaging.
Zhang H; Cao Y; Ren S; Guo K; Zhang Y; Lin T; Wang Y; Chen X; Wang Z
Technol Cancer Res Treat; 2023; 22():15330338231170942. PubMed ID: 37078135
[No Abstract] [Full Text] [Related]
18. Nomogram to predict malignancy in branch duct type intraductal papillary mucinous neoplasms.
Xu Y; Xie C; Gao Z; Zhang M; Zhan M
Medicine (Baltimore); 2022 Sep; 101(38):e30627. PubMed ID: 36197166
[TBL] [Abstract][Full Text] [Related]
19. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
